Arrowhead Pharmaceuticals Inc. (ARWR) Reports Q3 Loss of $0.96
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $82.39 --0%
Financial Fact:
Change in value of derivatives: -113.36K
Today's EPS Names:
PMCB, PLCE, DOMO, More
Financial Fact:
Change in value of derivatives: -113.36K
Today's EPS Names:
PMCB, PLCE, DOMO, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q3 EPS of ($0.96), versus ($0.68) reported last year. Revenue for the quarter came in at $15.8 million, versus $32.4 million reported last year.
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SailPoint Technologies Holdings (SAIL) PT Raised to $25 by Cantor Fitzgerald on Solid Checks
- Science Applications (SAIC) PT Raised to $154 at Stifel
- UBS Assumes Interactive Brokers Group (IBKR) at Neutral, 'A Best-in-Class, Yet Fairly Valued Brokerage'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
